Evaluation of difluprednate ophthalmic emulsionfor macular edema and neovascular desease
Not Applicable
- Conditions
- macular edema, neovascular eye desease
- Registration Number
- JPRN-UMIN000001432
- Lead Sponsor
- Yamagata University,Faculty of Medicine
- Brief Summary
Mean retinal thickness decreased significantly in patients who completed difluprednate ophthalmic emulsion instillation, and retinal thickness decreased by 20% or more in 37% of cases. No serious complications were observed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 84
Inclusion Criteria
Not provided
Exclusion Criteria
The patients with intraocular pressure more than 21 mmHg. Patients diagnosed as steroid responder.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method